PSU Profiles
Keywords
Last Name
Institution

Craig Meyers

TitleProfessor
InstitutionCollege of Medicine
DepartmentMicrobiology and Immunology
Address500 University Drive Hershey PA 17033
Mailbox: H107
Phone7175316240

 Overview 
 overview
PREFERRED TITLE/ROLE:

Distinguished Professor of Microbiology and Immunology

GRADUATE PROGRAM AFFILIATIONS:

Biomedical Sciences, Molecular Medicine, and MD/PhD Degree Program

EDUCATION:

B.S., Brigham Young University, Provo, UT, 1982
M.S., Brigham Young University, Provo, UT, 1984
Ph.D., University of California, Los Angeles, CA, 1990
Postdoctoral Training, Howard Hughes Medical Institute, University of Chicago, Chicago, IL 1990-1993


NARRATIVE:

The central research goals of my laboratory are to study the differentiation-dependent life cycle of human papillomavirus (HPV) and HPV-associated oncogenesis. My studies follow six general research themes: (1) Investigation of the molecular biology and genetics of HPV morphogenesis and structure in native virus replicated under natural physiological differentiation conditions of the host tissue. The majority of the laboratories studying HPV morphogenesis and structure utilize synthetic particles such as virus-like particles (VLPs) or pseudoviral particles (PsV). Our studies have shown that the morphogenesis, maturation, and structure of native HPV differs in many significant characteristic from VLPs or PsV particles. (2) Investigation of the efficacy of disinfectants and microbicides on native HPV as compared to VLPs/PsV. Our results demonstrate that HPV is significantly more resistant to disinfectants and microbicides then our VLPs/PsV. This demonstrates the clinical importance of using native HPV for disinfectant and microbicide testing. (3) Determining the mechanism whereby cofactors such as tobacco carcinogens increase carcinogenic progression in HPV-associated cancers. We are dissecting the signaling pathways and cell cycle components that are impacted by the interaction of cofactors and HPV in host tissue. (4) Determining the interaction of highly active anti-retroviral drugs on oral tissues, HPV and HPV’s infection of oral tissue. (5) Development of population science and basic science interactions to monitor, understand and influence education and behavior as they relate to a risk for acquiring an HPV-associated infection. (6) Comparative analysis of HPV infection, life cycle, and oncogenesis at different anatomical sites. (7) Investigation of AAV2 oncolytic properties. Including determine the mechanisms induced by AAV2 causing cancer cells to undergo cell death and translating these findings to the clinic.


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Cruz L, Meyers C. Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types. PLoS One. 2013; 8(7):e68379.
    View in: PubMed
  2. Karim R, Tummers B, Meyers C, Biryukov JL, Alam S, Backendorf C, Jha V, Offringa R, van Ommen GJ, Melief CJ, Guardavaccaro D, Boer JM, van der Burg SH. Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response. PLoS Pathog. 2013; 9(5):e1003384.
    View in: PubMed
  3. Trushin N, Alam S, El-Bayoumy K, Krzeminski J, Amin SG, Gullett J, Meyers C, Prokopczyk B. Comparative metabolism of benzo[a]pyrene by human keratinocytes infected with high-risk human papillomavirus types 16 and 18 as episomal or integrated genomes. J Carcinog. 2012; 11:1.
    View in: PubMed
  4. Mitchell D, Israr M, Alam S, Kishel J, Dinello D, Meyers C. Effect of the HIV nucleoside reverse transcriptase inhibitor zidovudine on the growth and differentiation of primary gingival epithelium. HIV Med. 2012 May; 13(5):276-90.
    View in: PubMed
  5. Alam S, Bowser BS, Conway MJ, Israr M, Tandon A, Meyers C. Adeno-associated virus type 2 infection activates caspase dependent and independent apoptosis in multiple breast cancer lines but not in normal mammary epithelial cells. Mol Cancer. 2011; 10:97.
    View in: PubMed
  6. Conway MJ, Cruz L, Alam S, Christensen ND, Meyers C. Differentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16. PLoS One. 2011; 6(7):e22427.
    View in: PubMed
  7. Bowser BS, Chen HS, Conway MJ, Christensen ND, Meyers C. Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus. Virus Res. 2011 Sep; 160(1-2):246-55.
    View in: PubMed
  8. Bodily JM, Mehta KP, Cruz L, Meyers C, Laimins LA. The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle. J Virol. 2011 Sep; 85(17):8852-62.
    View in: PubMed
  9. Wang X, Meyers C, Wang HK, Chow LT, Zheng ZM. Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol. 2011 Aug; 85(16):8080-92.
    View in: PubMed
  10. Karim R, Meyers C, Backendorf C, Ludigs K, Offringa R, van Ommen GJ, Melief CJ, van der Burg SH, Boer JM. Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS One. 2011; 6(3):e17848.
    View in: PubMed
  11. Bowser BS, Alam S, Meyers C. Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway. J Virol. 2011 May; 85(10):4982-92.
    View in: PubMed
  12. Wang X, Meyers C, Guo M, Zheng ZM. Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. Int J Cancer. 2011 Sep 15; 129(6):1362-72.
    View in: PubMed
  13. Chen HS, Conway MJ, Christensen ND, Alam S, Meyers C. Papillomavirus capsid proteins mutually impact structure. Virology. 2011 Apr 10; 412(2):378-83.
    View in: PubMed
  14. Conway MJ, Cruz L, Alam S, Christensen ND, Meyers C. Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes. PLoS One. 2011; 6(2):e16405.
    View in: PubMed
  15. Nguyen N, Sharma A, Nguyen N, Sharma AK, Desai D, Huh SJ, Amin S, Meyers C, Robertson GP. Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4. Cancer Prev Res (Phila). 2011 Feb; 4(2):248-58.
    View in: PubMed
  16. Israr M, Mitchell D, Alam S, Dinello D, Kishel JJ, Meyers C. The HIV protease inhibitor lopinavir/ritonavir (Kaletra) alters the growth, differentiation and proliferation of primary gingival epithelium. HIV Med. 2011 Mar; 12(3):145-56.
    View in: PubMed
  17. Gorbatyuk OS, Li S, Nguyen FN, Manfredsson FP, Kondrikova G, Sullivan LF, Meyers C, Chen W, Mandel RJ, Muzyczka N. a-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration. Mol Ther. 2010 Oct; 18(10):1758-68.
    View in: PubMed
  18. Chen HS, Bromberg-White J, Conway MJ, Alam S, Meyers C. Study of infectious virus production from HPV18/16 capsid chimeras. Virology. 2010 Sep 30; 405(2):289-99.
    View in: PubMed
  19. Chapman S, Liu X, Meyers C, Schlegel R, McBride AA. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest. 2010 Jul; 120(7):2619-26.
    View in: PubMed
  20. Gorbatyuk OS, Li S, Nash K, Gorbatyuk M, Lewin AS, Sullivan LF, Mandel RJ, Chen W, Meyers C, Manfredsson FP, Muzyczka N. In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration. Mol Ther. 2010 Aug; 18(8):1450-7.
    View in: PubMed
  21. Du P, Lemkin A, Kluhsman B, Chen J, Roth RE, MacEachren A, Meyers C, Zurlo JJ, Lengerich EJ. The roles of social domains, behavioral risk, health care resources, and chlamydia in spatial clusters of US cervical cancer mortality: not all the clusters are the same. Cancer Causes Control. 2010 Oct; 21(10):1669-83.
    View in: PubMed
  22. Alam S, Bowser BS, Conway MJ, Israr M, Ryndock EJ, Xi LF, Meyers C. Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene. J Virol. 2010 May; 84(9):4630-45.
    View in: PubMed
  23. Israr M, Mitchell D, Alam S, Dinello D, Kishel JJ, Meyers C. Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of primary gingival epithelium. Antivir Ther. 2010; 15(2):253-65.
    View in: PubMed
  24. Xi LF, Koutsky LA, Castle PE, Edelstein ZR, Meyers C, Ho J, Schiffman M. Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3490-6.
    View in: PubMed
  25. Conway MJ, Alam S, Christensen ND, Meyers C. Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines. Virology. 2009 Oct 25; 393(2):295-303.
    View in: PubMed
  26. Xi LF, Edelstein ZR, Meyers C, Ho J, Cherne SL, Schiffman M. Human papillomavirus types 16 and 18 DNA load in relation to coexistence of other types, particularly those in the same species. Cancer Epidemiol Biomarkers Prev. 2009 Sep; 18(9):2507-12.
    View in: PubMed
  27. Conway MJ, Alam S, Ryndock EJ, Cruz L, Christensen ND, Roden RB, Meyers C. Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J Virol. 2009 Oct; 83(20):10515-26.
    View in: PubMed
  28. Alam S, Meyers C. Adeno-associated virus type 2 induces apoptosis in human papillomavirus-infected cell lines but not in normal keratinocytes. J Virol. 2009 Oct; 83(19):10286-92.
    View in: PubMed
  29. Conway MJ, Meyers C. Replication and assembly of human papillomaviruses. J Dent Res. 2009 Apr; 88(4):307-17.
    View in: PubMed
  30. Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, Meyers C, Chow LT, Zheng ZM. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA. 2009 Apr; 15(4):637-47.
    View in: PubMed
  31. Lin Z, Yemelyanova AV, Gambhira R, Jagu S, Meyers C, Kirnbauer R, Ronnett BM, Gravitt PE, Roden RB. Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2. Am J Pathol. 2009 Jan; 174(1):136-43.
    View in: PubMed
  32. Jia R, Liu X, Tao M, Kruhlak M, Guo M, Meyers C, Baker CC, Zheng ZM. Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J Virol. 2009 Jan; 83(1):167-80.
    View in: PubMed
  33. Carty NC, Nash K, Lee D, Mercer M, Gottschall PE, Meyers C, Muzyczka N, Gordon MN, Morgan D. Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice. Mol Ther. 2008 Sep; 16(9):1580-6.
    View in: PubMed
  34. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One. 2008; 3(7):e2557.
    View in: PubMed
  35. Alam S, Conway MJ, Chen HS, Meyers C. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol. 2008 Jan; 82(2):1053-8.
    View in: PubMed
  36. Schweinfurth JM, Meyers C. Organotypic (raft) culture of biopsy-derived upper respiratory epithelium. Laryngoscope. 2006 Sep; 116(9):1600-2.
    View in: PubMed
  37. Alam S, Sen E, Brashear H, Meyers C. Adeno-associated virus type 2 increases proteosome-dependent degradation of p21WAF1 in a human papillomavirus type 31b-positive cervical carcinoma line. J Virol. 2006 May; 80(10):4927-39.
    View in: PubMed
  38. Drubin DA, McLaughlin-Drubin ME, Clawson GA, Meyers C. A protease inhibitor specifically inhibits growth of HPV-infected keratinocytes. Mol Ther. 2006 Jun; 13(6):1142-8.
    View in: PubMed
  39. Bodily JM, Alam S, Meyers C. Regulation of human papillomavirus type 31 late promoter activation and genome amplification by protein kinase C. Virology. 2006 May 10; 348(2):328-40.
    View in: PubMed
  40. Fang L, Meyers C, Budgeon LR, Howett MK. Induction of productive human papillomavirus type 11 life cycle in epithelial cells grown in organotypic raft cultures. Virology. 2006 Mar 30; 347(1):28-35.
    View in: PubMed
  41. Bodily, J.M., Alam, S., Chen, H.S., and Meyers, C. Papillomavirus Research: From Natural History To Vaccines and Beyond (Campo, M.S. ed.). Organotypic raft cultures and the study of the ntural history of papillomavirus. 2006.
  42. McLaughlin-Drubin ME, Bromberg-White JL, Meyers C. The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle. Virology. 2005 Jul 20; 338(1):61-8.
    View in: PubMed
  43. Sen E, McLaughlin-Drubin M, Meyers C. Efficacy of two commercial preparations of interferon-alpha on human papillomavirus replication. Anticancer Res. 2005 Mar-Apr; 25(2A):1091-100.
    View in: PubMed
  44. Alam S, Bromberg-White J, McLaughlin-Drubin M, Sen E, Bodily JM, Meyers C. Activity and therapeutic potential of ORI-1001 antisense oligonucleotide on human papillomavirus replication utilizing a model of dysplastic human epithelium. Anticancer Res. 2005 Mar-Apr; 25(2A):765-77.
    View in: PubMed
  45. Bodily JM, Meyers C. Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter. J Virol. 2005 Mar; 79(6):3309-21.
    View in: PubMed
  46. McLaughlin-Drubin ME, Meyers C. Propagation of infectious, high-risk HPV in organotypic "raft" culture. Methods Mol Med. 2005; 119:171-86.
    View in: PubMed
  47. Bodily JM, Meyers C. Analysis of HPV transcription by RPA. Methods Mol Med. 2005; 119:279-90.
    View in: PubMed
  48. McLaughlin-Drubin ME, Christensen ND, Meyers C. Propagation, infection, and neutralization of authentic HPV16 virus. Virology. 2004 May 1; 322(2):213-9.
    View in: PubMed
  49. McLaughlin-Drubin ME, Meyers C. Evidence for the coexistence of two genital HPV types within the same host cell in vitro. Virology. 2004 Apr 10; 321(2):173-80.
    View in: PubMed
  50. Sen E, Alam S, Meyers C. Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J Virol. 2004 Jan; 78(2):612-29.
    View in: PubMed
  51. Bromberg-White, J.L. and Meyers, C. Current Topics in Virol. The role of steroid hormones in human papilomavirus-induced cervical carcinogenesis. 2004; 3:183-199.
  52. Meyers C, Andreansky SS, Courtney RJ. Replication and interaction of herpes simplex virus and human papillomavirus in differentiating host epithelial tissue. Virology. 2003 Oct 10; 315(1):43-55.
    View in: PubMed
  53. Bromberg-White JL, Sen E, Alam S, Bodily JM, Meyers C. Induction of the upstream regulatory region of human papillomavirus type 31 by dexamethasone is differentiation dependent. J Virol. 2003 Oct; 77(20):10975-83.
    View in: PubMed
  54. Prasad CK, Meyers C, Zhan DJ, You H, Chiriva-Internati M, Mehta JL, Liu Y, Hermonat PL. The adeno-associated virus major regulatory protein Rep78-c-Jun-DNA motif complex modulates AP-1 activity. Virology. 2003 Sep 15; 314(1):423-31.
    View in: PubMed
  55. McLaughlin-Drubin ME, Wilson S, Mullikin B, Suzich J, Meyers C. Human papillomavirus type 45 propagation, infection, and neutralization. Virology. 2003 Jul 20; 312(1):1-7.
    View in: PubMed
  56. Bromberg-White JL, Meyers C. Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines. Virology. 2003 Feb 15; 306(2):197-202.
    View in: PubMed
  57. Bromberg-White JL, Meyers C. The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction. J Virol. 2002 Oct; 76(19):9702-15.
    View in: PubMed
  58. Steele BK, Meyers C, Ozbun MA. Variable expression of some "housekeeping" genes during human keratinocyte differentiation. Anal Biochem. 2002 Aug 15; 307(2):341-7.
    View in: PubMed
  59. Sen E, Bromberg-White JL, Meyers C. Genetic analysis of cis regulatory elements within the 5' region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J Virol. 2002 May; 76(10):4798-809.
    View in: PubMed
  60. Meyers C, Bromberg-White JL, Zhang J, Kaupas ME, Bryan JT, Lowe RS, Jansen KU. Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera. J Virol. 2002 May; 76(10):4723-33.
    View in: PubMed
  61. Meyers, C. Methods in Tissue Engineering (Atala, A. and Lanza, R. eds. Three-dimensional cervical epithelial culture system. 2002.
  62. Meyers C, Alam S, Mane M, Hermonat PL. Altered biology of adeno-associated virus type 2 and human papillomavirus during dual infection of natural host tissue. Virology. 2001 Aug 15; 287(1):30-9.
    View in: PubMed
  63. Southern SA, Noya F, Meyers C, Broker TR, Chow LT, Herrington CS. Tetrasomy is induced by human papillomavirus type 18 E7 gene expression in keratinocyte raft cultures. Cancer Res. 2001 Jun 15; 61(12):4858-63.
    View in: PubMed
  64. Meyers C, Mane M, Kokorina N, Alam S, Hermonat PL. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model. Virology. 2000 Jul 5; 272(2):338-46.
    View in: PubMed
  65. Mayer, T.J., Frauenhoffer, E., and Meyers, C. In Vitro. Expression of epidermal growth factor receptor and platelet-derived growth factor receptor during cervical carcinogenesis. 2000; 36:667-676.
  66. Shier MK, Neely EB, Ward MG, Meyers C, Howett MK. Transforming growth factor beta 1 (TGF beta 1) down-regulates expression and function of proliferation-inducing molecules in HPV-transformed cells. Anticancer Res. 1999 Nov-Dec; 19(6B):4977-82.
    View in: PubMed
  67. Shier MK, Neely EB, Ward MG, Richards ME, Manders EC, Meyers C, Howett MK. Correlation of TGF beta 1 overexpression with down-regulation of proliferation-inducing molecules in HPV-11 transformed human tissue xenografts. Anticancer Res. 1999 Nov-Dec; 19(6B):4969-76.
    View in: PubMed
  68. Zhan D, Santin AD, Liu Y, Parham GP, Li C, Meyers C, Hermonat PL. Binding of the human papillomavirus type 16 p97 promoter by the adeno-associated virus Rep78 major regulatory protein correlates with inhibition. J Biol Chem. 1999 Oct 29; 274(44):31619-24.
    View in: PubMed
  69. Ozbun MA, Meyers C. Two novel promoters in the upstream regulatory region of human papillomavirus type 31b are negatively regulated by epithelial differentiation. J Virol. 1999 Apr; 73(4):3505-10.
    View in: PubMed
  70. Ozbun, M.A. and Meyers, C. Current Topics in Virol. Human papillomavirus type 31b transcription during the differentiation-dependent viral life cycle. 1999; 1:203-217.
  71. Ozbun MA, Meyers C. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology. 1998 Sep 1; 248(2):218-30.
    View in: PubMed
  72. Mayer TJ, Meyers C. Temporal and spatial expression of the E5a protein during the differentiation-dependent life cycle of human papillomavirus type 31b. Virology. 1998 Sep 1; 248(2):208-17.
    View in: PubMed
  73. Hermonat PL, Meyers C, Parham GP, Santin AD. Inhibition/stimulation of bovine papillomavirus by adeno-associated virus is time as well as multiplicity dependent. Virology. 1998 Aug 1; 247(2):240-50.
    View in: PubMed
  74. Ozbun MA, Meyers C. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J Virol. 1998 Apr; 72(4):2715-22.
    View in: PubMed
  75. Meyers, C., Frattini, M.G., and Laimins, L.A. Cell Biology: A laboratory Handbook (Celis, J.E. ed.). Tissue culture techniques for the study of human papillomaviruses in stratified epihtelia. 1998.
  76. Meyers C, Mayer TJ, Ozbun MA. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J Virol. 1997 Oct; 71(10):7381-6.
    View in: PubMed
  77. Ozbun MA, Meyers C. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J Virol. 1997 Jul; 71(7):5161-72.
    View in: PubMed
  78. Visalli RJ, Courtney RJ, Meyers C. Infection and replication of herpes simplex virus type 1 in an organotypic epithelial culture system. Virology. 1997 Apr 14; 230(2):236-43.
    View in: PubMed
  79. Ozbun MA, Meyers C. Transforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes. J Virol. 1996 Aug; 70(8):5437-46.
    View in: PubMed
  80. Meyers, C. Methods in Cell Science. Organotypic (raft) epithelial culture system for the study of the differentiation-dependent replication of papillomavirus. 1996; 18:201-210.
  81. Meyers C, Laimins LA. In vitro systems for the study and propagation of human papillomaviruses. Curr Top Microbiol Immunol. 1994; 186:199-215.
    View in: PubMed
  82. Wagner AJ, Meyers C, Laimins LA, Hay N. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 1993 Nov; 4(11):879-83.
    View in: PubMed
  83. Meyers C, Frattini MG, Hudson JB, Laimins LA. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science. 1992 Aug 14; 257(5072):971-3.
    View in: PubMed
  84. Meyers C, Harry J, Lin YL, Wettstein FO. Identification of three transforming proteins encoded by cottontail rabbit papillomavirus. J Virol. 1992 Mar; 66(3):1655-64.
    View in: PubMed
  85. Meyers, C. and Laimins, L.A. Papillomavirus Reports. In vitro model systems for the study of HPV-induced neoplasia. 1992; 3:1-3.
  86. Meyers C, Wettstein FO. The late region differentially regulates the in vitro transformation by cottontail rabbit papillomavirus DNA in different cell types. Virology. 1991 Apr; 181(2):637-46.
    View in: PubMed
  87. Gage JR, Meyers C, Wettstein FO. The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J Virol. 1990 Feb; 64(2):723-30.
    View in: PubMed
  88. Nasseri M, Meyers C, Wettstein FO. Genetic analysis of CRPV pathogenesis: the L1 open reading frame is dispensable for cellular transformation but is required for papilloma formation. Virology. 1989 May; 170(1):321-5.
    View in: PubMed
  89. Jensen MM, Downs WC, Morrey JD, Nicoll TR, LeFevre SD, Meyers CM. Staphylococcosis of turkeys. 1. Portal of entry and tissue colonization. Avian Dis. 1987 Jan-Mar; 31(1):64-9.
    View in: PubMed
  90. Meyers CM, Jensen MM. Staphylococcosis of turkeys. 3. Bacterial interference as a possible means of control. Avian Dis. 1987 Jan-Mar; 31(1):74-9.
    View in: PubMed
  91. Jensen, M.M. and Meyers, C.M. The Staphylococci. J. Jeljaszewicz (Ed.). Pathogenesis of Staphylococcosis in turkeys and its control by colonization with avirulent staphylococcin-producing Staphylococci. 1985.
Meyers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_